Hill JW, Tansavatdi K, Lockett KL, Allen GO, Takita C, Pollack A, Hu JJ. (2009) Validation of the cell cycle G₂ delay assay in assessing ionizing radiation sensitivity and breast cancer risk. Cancer. Cancer Management and Research 1:39-48.

 

Nieder AM, MacKinnon JA, Fleming LE, Kearney G, Hu JJ, Sherman RL, Huang Y, Lee DJ. (2009) Bladder cancer clusters in Florida: identifying populations at risk. J Urol 182:46-50.

 

Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, Sun J, Isaacs SD, Wiley KE, Kim ST, Hsu FC, Wu W, Torti FM, Walsh PC, Chang BL, Isaacs WB. (2009) Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev 18:2145-9.

 

Zabaleta J, Su LJ, Lin HY, Sierra RA, Hall MC, Sartor AO, Clark PE, Hu JJ, Ochoa AC. (2009) Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis 30:1358-62.

 

Van Emburgh BO, Hu JJ, Levine EA, Mosley LJ, Case LD, Lin HY, Knight SN, Perrier ND, Rubin P, Sherrill GB, Shaw CS, Carey LA, Sawyer LR, Allen GO, Milikowski C, Willingham MC, Miller MS. (2008) Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer. Mol Carcinog 47:88-99.

 

Van Emburgh BO, Hu JJ, Levine EA, Mosley LJ, Perrier ND, Freimanis RI, Allen GO, Rubin P, Sherrill GB, Shaw CS, Carey LA, Sawyer LR, Miller MS. (2008) Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer. Oncol Rep 19:1311-21.

 

Hill JW, Hu JJ, Evans MK. (2008) OGG1 is degraded by calpain following oxidative stress and cisplatin exposure. DNA Repair (Amst) 7:648-54.

 

Zabaleta J, Lin HY, Sierra RA, Hall MC, Clark PE, Sartor OA, Hu JJ, Ochoa AC. (2008) Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis 29:573-8.

 

Goodwin WJ, Thomas GR, Parker DF, Joseph D, Levis S, Franzmann E, Anello C, Hu JJ. (2008) Unequal burden of head and neck cancer in the United States. Head Neck 30:358-71.